MaxCyte, Inc.MXCTNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +2.00% | -44.51% | -8.39% | -18.43% | -16.35% |
| Gross Profit Growth | -13.52% | -54.50% | -10.52% | -21.84% | +1.23% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.60% | +1.11% | +1.79% | +1.69% | +1.16% |
| Weighted Average Shares Diluted Growth | +1.60% | +1.11% | +1.79% | +1.69% | +1.16% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -896.68% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | -12010.31% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -44.16% | -18.97% | -7.78% | +25.58% | +82.15% |
| Inventory Growth | -17.07% | -27.11% | -30.82% | -28.91% | -26.77% |
| Asset Growth | -6.79% | -10.74% | -10.84% | -12.62% | -14.13% |
| Book Value per Share Growth | -10.05% | -12.13% | -13.45% | -15.23% | -16.45% |
| Debt Growth | +13.91% | -3.78% | +0.98% | -0.11% | -0.86% |
| R&D Expense Growth | -15.13% | -21.02% | -11.61% | +11.57% | +0.00% |
| SG&A Expenses Growth | +0.62% | -10.49% | -1.69% | -2.74% | -28.77% |